Outbreak Investigation


  • New England Compounding Center Establishes Recall Operations Center
    New England Compounding Pharmacy, Inc. (doing business as New England Compounding Center -- NECC) announces that it has established a Recall Operations Center to process and manage the removal of all NECC products from circulation. As a precautionary measure, due to the ...More
    October 11, 2012 Posted in News
  • Update on Multistate Meningitis Outbreak Investigation
    The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently coordinating a multistate investigation of fungal meningitis among patients who received an epidural steroid injection with a potentially contaminated product. ...More
    October 10, 2012 Posted in News
  • CDC Issues Final Update on Salmonella Infections Linked to Cantaloupe
    The Centers for Disease Control and Prevention (CDC) has issued a final investigation update regarding the multistate outbreak of Salmonella Typhimurium and Salmonella Newport infections linked to cantaloupe. ...More
    October 8, 2012 Posted in News
  • Update on Nationwide Meningitis Outbreak
    In response to a nationwide outbreak of meningitis and stroke associated with a widely distributed medication, the Centers for Disease Control and Prevention (CDC) is providing updated guidance to clinicians and patients about contaminated medication products received from ...More
    October 8, 2012 Posted in News
  • NECC Issues Statement on Meningitis Outbreak
    On Oct. 4, 2012, the New England Compounding Center issued the following statement: “New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy, the Centers for Disease Control and the U.S. Food and Drug Administration on their ...More
    October 8, 2012 Posted in News
  • FDA Offers Questions and Answers on Fungal Meningitis Outbreak
    The Food and Drug Administration (FDA) offers the following Q&A on the current fungal meningitis outbreak. Q. What is FDA’s role in the investigation? A. FDA was been working closely with CDC, several state health departments, and the Massachusetts Board of Pharmacy to ...More
    October 8, 2012 Posted in News
  • Genotyping Helps Identify Source of Clinic Infection Outbreak
    Researchers from East Carolina University used a new technique of genotyping to identify the source of a hematology clinic outbreak of Mycobacterium mucogenicum, a Gram-positive, acid-fast bacteria found in tap water. This is the first outbreak of M. mucogenicum in an ...More
    October 5, 2012 Posted in News
  • CDC, FDA Provide Update on Meningitis Outbreak Associated with Fungus-Tainted Injectible Steroid
    On Oct. 4, 2012, the CDC and FDA hosted a briefing to discuss the multi-state investigation of meningitis among patients who have received epidural steroid injections. According to Benjamin Park, MD, medical officer, Mycotic Diseases Branch, Division of Foodborne, ...More
    October 4, 2012 Posted in News
  • Investigation of MedSpa Group A Streptococcus Cases is Expanded
    During the week of Sept 17, 2012, the Maryland Department of Health and Mental Hygiene (DHMH) and the Baltimore County Department of Health began investigating a cluster of three severe invasive Group A Streptococcus (GAS) infections in persons who recently had liposuction ...More
    October 3, 2012 Posted in News
  • Minnesota Department of Health Releases Analysis of St. Cloud Hospital Bloodstream Infection Outbreak
    The Minnesota Department of Health (MDH) has released a final report about its investigation into an outbreak of bloodstream infections at St. Cloud Hospital in 2011 that was associated with a healthcare worker diverting narcotics from intravenous (IV) bags. On Feb. 21, ...More
    October 2, 2012 Posted in News